ZFP14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.180400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.502400E-01
Normal-vs-Stage2
3.050800E-01
Normal-vs-Stage3
1.889570E-01
Normal-vs-Stage4
2.992200E-01
Stage1-vs-Stage2
4.012400E-02
Stage1-vs-Stage3
3.542000E-02
Stage1-vs-Stage4
5.797600E-01
Stage2-vs-Stage3
1.644870E-03
Stage2-vs-Stage4
4.122400E-01
Stage3-vs-Stage4
3.423800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.216200E-01
Normal-vs-AfricanAmerican
3.133400E-01
Normal-vs-Asian
6.043900E-02
Caucasian-vs-AfricanAmerican
8.725600E-01
Caucasian-vs-Asian
5.395800E-01
AfricanAmerican-vs-Asian
8.008000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.258400E-01
Normal-vs-Female
3.113000E-01
Male-vs-Female
6.616400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.849800E-01
Normal-vs-Age(41-60Yrs)
3.564800E-01
Normal-vs-Age(61-80Yrs)
3.044000E-01
Normal-vs-Age(81-100Yrs)
2.717400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.515000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.908400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.785850E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.781400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.534630E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.206200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.858000E-01
Normal-vs-Daily Drinker
2.683200E-01
Normal-vs-Weekly Drinker
2.472600E-01
Normal-vs-Occasional Drinker
6.956000E-02
Normal-vs-Social Drinker
7.062100E-02
Non Drinker-vs-Daily Drinker
7.128600E-01
Non Drinker-vs-Weekly Drinker
4.448400E-01
Non Drinker-vs-Occasional Drinker
2.011000E-01
Non Drinker-vs-Social Drinker
4.322800E-01
Daily Drinker-vs-Weekly Drinker
6.583600E-01
Daily Drinker-vs-Occasional Drinker
1.234950E-01
Daily Drinker-vs-Social Drinker
2.939600E-01
Weekly Drinker-vs-Occasional Drinker
8.254400E-02
Weekly Drinker-vs-Social Drinker
1.987160E-01
Occasional Drinker-vs-Social Drinker
7.285200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.494500E-02
Normal-vs-Grade 2
7.536300E-03
Normal-vs-Grade 3
4.757600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.734830E-01
Grade 1-vs-Grade 3
3.227800E-01
Grade 1-vs-Grade 4
3.494500E-02
Grade 2-vs-Grade 3
5.883800E-01
Grade 2-vs-Grade 4
7.536300E-03
Grade 3-vs-Grade 4
4.757600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.886400E-01
Normal-vs-NonDiabetic
3.053200E-01
Diabetic-vs-NonDiabetic
6.178800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.433800E-01
Normal-vs-NoPancreatitis
3.121400E-01
Pancreatitis-vs-NoPancreatitis
1.719820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.194300E-02
Normal-vs-N1
3.040200E-01
N0-vs-N1
3.781600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.645800E-01
Normal-vs-TP53-NonMutant
4.944800E-01
TP53-Mutant-vs-TP53-NonMutant
3.124300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
